March 3, 2017

New CEO takes the lead at Eagle Genomics Ltd.

Eagle Genomics Ltd., the leading open-source bioinformatics consultancy, this week welcomed its new Chief Executive, David Flanders, to lead the organisation from its Babraham head office near Cambridge.

David brings more than 25 years' international experience in the bioinformatics and life sciences sector. He will strategically lead company growth as it capitalizes on the multi-sector need for bioinformatics services arising from recent advances in sequencing technologies. Founding CEO, Abel Ureta-Vidal, remains full time with the company as Chief Operating Officer, where he will focus on operations to support growth and to maintain Eagle’s reputation for high-quality project delivery to customers.

David said, “I was immediately impressed by how professional the Eagle team is, and how dedicated they are to delivering excellent service to their customers. I look forward to working with them to expand into new areas and diversify their already impressive customer portfolio of major international biotechnology and pharmaceutical companies.”

Abel said, “After over three years as CEO, it is now the right time for a more experienced executive to bring the company to the next level. I am pleased to welcome David and look forward to working with him as Eagle enters a period of rapid growth. In my role as COO, I shall focus on internal efficiency and front-line project delivery to ensure that Eagle’s customers continue to get the best quality service.”

Eagle’s Chairman, Alan Barrell, said: “We are thrilled to have David join us at Eagle and we are confident that he will use his experience to build upon Eagle’s solid reputation and extend our services into a range of exciting new areas.”

David is former Site Head for the UK operation of a US R&D and manufacturing biotechnology company, and also COO of a proteomics and systems biology start-up, as well as Senior Director of a major bioinformatics provider. He has US experience both in the agricultural technology industry and at Stanford University. David has a PhD in Developmental Biology from the Australian National University.

Topics: Announcements